NFKB1 and cancer: Which signalling pathways are activated by CXCL1 through CXCR2 in dendritic cells is yet unknown, however studies in different cell types, such as cancer cells, show that CXCR2 signalling can activate NF-κB, STAT3 and the ERK pathways [38], [39], [40].